“We do see good antibody levels both in the phase one and the phase two (trials), so we’re pretty hopeful,” Gates told CNBC.
Bill Gates doesn’t expect a virus vaccine before year-end — but he says one drugmaker has the best chance
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push